Hasil Pencarian  ::  Simpan CSV :: Kembali

Hasil Pencarian

Ditemukan 1 dokumen yang sesuai dengan query
cover
Andika Afriansyah
" ABSTRAK
In the past 10 years, recent development of targeted therapy in metastatic renal cell carcinoma (mRCC) has provided a new hope and significantly enhanced the prognosis of the disease. Three class of targeted therapy were developed, including multi-targeted tyrosine kinase inhibitors (TKI), the mammalian target of rapamycin (mTOR) complex-1 kinase inhibitors, and the humanized antivascular endothelial growth factor (VEGF) monoclonal antibody. Hence, the objective of this article was to critically examine the current evidence of ... "
Jakarta: University of Indonesia. Faculty of Medicine, 2016
610 IJIM 48:4 (2016)
Artikel Jurnal  Universitas Indonesia Library